Imagion Biosystems Ltd Asset Resilience Ratio

Latest as of June 2020: 75.37%

Imagion Biosystems Ltd asset resilience ratio. Imagion Biosystems Ltd (IBX) has an Asset Resilience Ratio of 75.37% as of June 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IBX defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$4.33 Million

≈ $3.06 Million USD Cash + Short-term Investments

Total Assets

AU$5.74 Million

≈ $4.06 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Imagion Biosystems Ltd (2016–2019)

Asset resilience ratio of Imagion Biosystems Ltd from 2016 to 2019. This chart shows how Imagion Biosystems Ltd's Asset Resilience Ratio has changed over time. Read IBX total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Imagion Biosystems Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Imagion Biosystems Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$4.33 Million	75.37%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$4.33 Million	75.37%

Asset Resilience Insights

Very High Liquidity: Imagion Biosystems Ltd maintains exceptional liquid asset reserves at 75.37% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Imagion Biosystems Ltd Industry Peers by Asset Resilience Ratio

Compare Imagion Biosystems Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Lonza Group AG SW:LONN	Diagnostics & Research	3.04%
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Dr. Lal Path Labs Ltd. NSE:LALPATHLAB	Diagnostics & Research	13.43%
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Prodia Widyahusada Tbk PT JK:PRDA	Diagnostics & Research	7.82%
Scope Fluidics SA WAR:SCP	Diagnostics & Research	16.51%

Imagion Biosystems Ltd Asset Resilience Ratio by Year (2016–2019)

Imagion Biosystems Ltd asset resilience ratio by year from 2016 to 2019. The table below shows the annual Asset Resilience Ratio data for Imagion Biosystems Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	69.82%	AU$3.40 Million ≈ $2.41 Million	AU$4.87 Million ≈ $3.45 Million	-14.37pp
2018-12-31	84.19%	AU$4.37 Million ≈ $3.09 Million	AU$5.19 Million ≈ $3.67 Million	-5.76pp
2017-12-31	89.94%	AU$6.87 Million ≈ $4.86 Million	AU$7.64 Million ≈ $5.41 Million	+89.72pp
2016-12-31	0.23%	AU$27.64K ≈ $19.56K	AU$12.14 Million ≈ $8.59 Million	--

pp = percentage points

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$1.74 Million

AU$2.45 Million AUD

Market Cap Rank

#30188 Global

#1758 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$8.60